Related Experiment Videos
Limbic forebrain toxin trimethyltin reduces behavioral suppression by clonidine
R B Messing1, V Devauges, S J Sara
1Départment de Psychophysiologie, L.P.N.-C.N.R.S. Gif-sur-Yvette, France.
Pharmacology, Biochemistry, and Behavior
|June 1, 1992
Summary
Trimethyltin (TMT) poisoning impairs noradrenergic neurotransmission, affecting cognitive functions. Clonidine, an alpha 1-adrenergic agonist, showed reduced effectiveness in TMT-treated rats, supporting this hypothesis.
Area of Science:
- Neuroscience
- Toxicology
- Pharmacology
Background:
- Trimethyltin (TMT) exposure causes hippocampus damage and cognitive deficits.
- TMT exposure is associated with altered beta-adrenergic ligand binding in the forebrain.
- Reduced noradrenergic neurotransmission is hypothesized to contribute to TMT-induced cognitive impairment.
Purpose of the Study:
- To investigate the role of noradrenergic neurotransmission in TMT-induced cognitive deficits.
- To test the hypothesis that alpha 1-adrenergic agonists are less effective in TMT-poisoned rats.
Main Methods:
- Rats were administered TMT (6 mg/kg) or a vehicle control.
- Animals received saline or clonidine (5, 10, or 20 µg/kg) 30 minutes prior to testing.
- Exploratory activity was assessed using a hole-board apparatus.
Main Results:
- Clonidine (10 µg/kg) significantly reduced exploratory activity in control rats but was ineffective in TMT-treated rats.
- Higher clonidine doses (20 µg/kg) showed non-significant reductions in TMT-treated rats due to increased response variability.
- TMT-treated rats exhibited impaired responses to clonidine compared to controls.
Conclusions:
- The findings suggest an impairment of noradrenergic neurotransmission following TMT poisoning.
- This impairment may underlie the learning and memory deficits observed after TMT exposure.
- Alpha 1-adrenergic pathways are potentially affected by TMT toxicity.